Target (CBDY) Share-based Compensation Growth (1y) (2016 - 2023)
Target (CBDY) Share-based Compensation Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 26.47% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 47.06% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.60% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 8.33% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -69.71% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 40.00% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 59.27% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -24.33% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 23.92% |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 5,391.67% |
| Jun 30, 2023 | 77.30% |
| Mar 31, 2023 | -61.75% |
| Dec 31, 2022 | 76.09% |
| Sep 30, 2022 | -101.10% |
| Jun 30, 2022 | -112.89% |
| Mar 31, 2022 | -69.41% |
| Dec 31, 2021 | 170.26% |
| Sep 30, 2021 | -83.42% |
| Jun 30, 2021 | 2,911.90% |
| Mar 31, 2021 | 887.56% |
| Dec 31, 2020 | -100.16% |
| Dec 31, 2019 | 764.42% |
| Dec 31, 2018 | -20.36% |
| Jun 30, 2018 | -89.44% |
| Mar 31, 2018 | -43.45% |
| Dec 31, 2017 | 92,288.00% |
| Sep 30, 2017 | -63.76% |
| Mar 31, 2017 | -75.93% |
| Dec 31, 2016 | -99.99% |